Sarah A Spinler

Learn More
BACKGROUND The 2 fundamental approaches to the management of atrial fibrillation (AF) are reestablishing and maintaining sinus rhythm (rhythm control) and controlling ventricular rate with atrioventricular node blocking agents (rate control). We performed a meta-analysis of randomized controlled trials comparing these strategies in patients with AF to add(More)
The strategic plan of the American College of Clinical Pharmacy (ACCP) presents a vision for the future of the pharmacy profession that includes the following statement: " Formal, postgraduate residency training will become mandatory before one can enter practice. " 1 In this article, we articulate the foundation of ACCP's future vision for residency(More)
M edical errors are the eighth leading cause of death in the United States and are estimated to account for somewhere between 44 000 and 98 000 deaths in the United States each year. 1 An exact number of deaths remains both uncertain and controversial, with arguments that the actual figure may be lower 2 or higher. 3 Each year in the United States, the(More)
Anticoagulant drugs are the foundation of therapy for patients with VTE. While effective therapeutic agents, anticoagulants can also result in hemorrhage and other side effects. Thus, anticoagulant therapy selection should be guided by the risks, benefits and pharmacologic characteristics of each agent for each patient. Safe use of anticoagulants requires(More)
  • S A Spinler
  • 2005
To cite this article: Spinler SA. The skinny on treatment of venous thromboembolism in obesity. The influence of extreme body weight on clinical outcome of patients with venous thromboembolism: findings from a prospective registry (RIETE). The World Health Organization estimates that worldwide, more than 300 million persons are obese [1]. Obesity and(More)
Anticoagulant drugs are the foundation of therapy for patients with VTE. While effective therapeutic agents, anticoagulants can also result in hemorrhage and other side effects. Thus, anticoagulant therapy selection should be guided by the risks, benefits and pharmacologic characteristics of each agent for each patient. Safe use of anticoagulants requires(More)
Editor must not exceed 400 words in length and may be subject to editing or abridgment. Letters must be limited to three authors and five references. They should not have tables or figures and should relate solely to an article published in Circulation within the preceding 12 weeks. Only some letters will be published. Authors of those selected for(More)
  • 1